Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials
Description
This statement provides guidance to clinical trial applicants about the investigational use of marketed drugs within clinical trials in Canada.
Resources
| Name |
Format |
Description |
Link |
|
21 |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-statement-investigational-use-marketed-drugs-clinical-trials.html |
|
21 |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-declaration-utilisation-experimentale-medicaments-commercialises-essais-cliniques.html |